Compare Aterian Inc (ATER) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aterian Inc vs Novartis AG — how do they compare? Aterian Inc trades at $0.48 (market cap $5.32M), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 55520.7× Aterian Inc's market cap, and Novartis AG pays a 3.07% dividend while Aterian Inc pays none. Which is the better fit depends on your goals.
| ATER | NVS | |
|---|---|---|
Market Cap | $5.32M | $295.37B |
Sector | Consumer Cyclical | Health |
52-Week High | $1.39 | $168.62 |
52-Week Low | $0.36 | $119.31 |
Enterprise Value | $5.90M | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
